Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Guenther Koehne

Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Biology of Blood and Marrow Transplantation
Volume	26
State	Published - Nov 1 2020

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{045aeafc150b4ab2b5f414bec9817426,

title = "Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma",

author = "Guenther Koehne",

note = "Biology of Blood and Marrow Transplantation (2020) 26(11):2040-2046",

year = "2020",

month = nov,

day = "1",

language = "American English",

volume = "26",

journal = "Biology of Blood and Marrow Transplantation",

}

TY - JOUR

T1 - Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

AU - Koehne, Guenther

N1 - Biology of Blood and Marrow Transplantation (2020) 26(11):2040-2046

PY - 2020/11/1

Y1 - 2020/11/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3616

M3 - Article

VL - 26

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

ER -

Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Access to Document

Other files and links

Cite this